Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8993)
All Articles published online
|
Publishing Process of This Article
|
Apr 16, 2023 (publication date) through Dec 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Zhu Q, Gao BQ, Zhang JF, Shi LP, Zhang GQ. Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports. World J Clin Cases 2023; 11(11): 2549-2558 [PMID: 37123319 DOI: 10.12998/wjcc.v11.i11.2549] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Zhu Q, Gao BQ, Zhang JF, Shi LP, Zhang GQ. Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports. World J Clin Cases 2023; 11(11): 2549-2558 [PMID: 37123319 DOI: 10.12998/wjcc.v11.i11.2549] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i11/2549.htm |
| Number | Citing Articles |
| 1 |
Benedetta Tirone, Gerardo Cazzato, Francesca Ambrogio, Caterina Foti, Marco Bellino. Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic Option. Diseases 2024; 12(5): 94 doi: 10.3390/diseases12050094
|
| 2 |
Feiying Guo, Huajie Zhong, Yuan Wu, Xue Xu, Jiarong Tan, Qiang Zhou, Shunli Tang. Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature review. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1485079
|
| 3 |
Alexandru-Florin Florescu, Oana-Claudia Sima, Claudiu Nistor, Mihai-Lucian Ciobica, Mihai Costachescu, Mihaela Stanciu, Denisa Tanasescu, Florina Ligia Popa, Mara Carsote. Endocrine Perspective of Cutaneous Lichen Amyloidosis: RET-C634 Pathogenic Variant in Multiple Endocrine Neoplasia Type 2. Clinics and Practice 2024; 14(6): 2284 doi: 10.3390/clinpract14060179
|
| 4 |
Seitaro Nakagawa, Ikuko Ueda-Hayakawa, Manabu Fujimoto. Nemolizumab for treatment of lichen amyloidosis. JAAD Case Reports 2025; 63: 41 doi: 10.1016/j.jdcr.2025.06.010
|
| 5 |
Rachel L. Ziebart, Jason C. Sluzevich. Remission of lichen amyloidosis achieved with upadacitinib: A case report. JAAD Case Reports 2025; 65: 26 doi: 10.1016/j.jdcr.2025.06.061
|
| 6 |
Wenxin Zhang, Dandan Mao, Cheng Zhou, Guangdong Wen. Improvement of Low-Dose Abrocitinib-Resistant Lichen Amyloidosis with Dupilumab: Two Case Reports. Clinical, Cosmetic and Investigational Dermatology 2025; : 3087 doi: 10.2147/CCID.S555311
|
| 7 |
Yizhen Zhang, Dawei Huang, Yunlu Gao. Case report: Abrocitinib: a potential therapeutic option for lichen amyloidosis associated with atopic dermatitis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1477664
|
| 8 |
Qin-Xiao Wang, Qian Ye, Kai-Yi Zhou, Si-Yu Luo, Sheng Fang. Systematic review and meta-analysis of treatments and outcomes in primary localized cutaneous amyloidosis. Clinical and Experimental Dermatology 2025; 50(7): 1343 doi: 10.1093/ced/llaf081
|
| 9 |
Pan Zou, Yuxin Du, Yuchun Cao, Hongxiang Chen, Yi Duan. Treatment of primary cutaneous amyloidosis with tofacitinib: preliminary observations from a single-arm clinical trial. Clinical and Experimental Dermatology 2025; doi: 10.1093/ced/llaf364
|
| 10 |
M. Amiot, I. Moulonguet. Amylose papuleuse (« lichen amyloïde »). Annales de Dermatologie et de Vénéréologie - FMC 2024; 4(7): 471 doi: 10.1016/j.fander.2023.10.014
|